SCHEMBL29910593

SCHEMBL29910593

Nc1ccccc1-c1cc(N2CC3CCC(C2)N3c2cccc(CN3CCN(C(=O)OCc4ccccc4)CC3)c2)c(N)nn1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 5/20 0.46
▸ SMARCA4 P51532 5/20 0.46
▸ PBRM1 Q86U86 7/20 0.41
▸ OPRM1 P35372 1/20 0.39
▸ TMEM97 Q5BJF2 1/20 0.38
▸ SIGMAR1 Q99720 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ CHRM4 P08173 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ HDAC1 Q13547 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23301401 1.00 SMARCA2 (0.46) SMARCA2SMARCA4PBRM1OPRM1TMEM97
SCHEMBL29943157 0.95 SMARCA2 (0.53) SMARCA2SMARCA4PBRM1OPRM1
SCHEMBL30797027 0.95 SMARCA2 (0.53) SMARCA2SMARCA4PBRM1OPRM1
SCHEMBL23301459 0.95 SMARCA2 (0.53) SMARCA2SMARCA4PBRM1OPRM1
SCHEMBL29910839 0.90 SMARCA2 (0.46) SMARCA2SMARCA4PBRM1OPRM1TMEM97
SCHEMBL23301166 0.90 SMARCA2 (0.46) SMARCA2SMARCA4PBRM1OPRM1TMEM97
SCHEMBL23301307 0.89 OPRM1 (0.43) SMARCA2SMARCA4OPRM1TMEM97SIGMAR1
SCHEMBL30796426 0.89 OPRM1 (0.43) SMARCA2SMARCA4OPRM1TMEM97SIGMAR1
SCHEMBL29910532 0.89 OPRM1 (0.43) SMARCA2SMARCA4OPRM1TMEM97SIGMAR1
SCHEMBL29943546 0.86 SMARCA2 (0.48) SMARCA2SMARCA4PBRM1CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4054724-A1 BIFUNCTIONAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2022-09-14 — — EP disclosed
EP-4051674-A1 BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2022-09-07 — — EP disclosed
Send feedback